AI Verdict
IBRX has stronger fundamentals based on our AI analysis.
IBRX vs IBIT Fundamental Comparison
| Metric | IBRX | IBIT |
|---|---|---|
| Revenue | $113.3M | N/A |
| Net Income | $-351.4M | $-9.0B |
| Net Margin | -310.2% | N/A |
| ROE | N/A | N/A |
| ROA | -70.0% | N/A |
| Current Ratio | 5.10x | N/A |
| Debt/Equity | N/A | N/A |
| EPS | $-0.38 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBRX vs IBIT: Frequently Asked Questions
Is IBRX or IBIT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBRX has stronger fundamentals. IBRX is rated STRONG SELL (92% confidence) while IBIT is rated STRONG SELL (85% confidence). This is not investment advice.
How does IBRX compare to IBIT fundamentally?
ImmunityBio, Inc. has ROE of N/A vs iShares Bitcoin Trust ETF's N/A. Net margins are -310.2% vs N/A respectively.
Which stock pays higher dividends, IBRX or IBIT?
IBRX has a dividend yield of N/A or no dividend while IBIT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBRX or IBIT for long term?
For long-term investing, consider that IBRX has STRONG SELL rating with 92% confidence, while IBIT has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBRX vs IBIT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBRX vs IBIT, the AI consensus favors IBRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.